TIQRX
Price
$42.39
Change
-$0.50 (-1.17%)
Updated
Jun 13 closing price
Net Assets
51.05B
VTSAX
Price
$142.91
Change
-$1.69 (-1.17%)
Updated
Jun 13 closing price
Net Assets
1.82T
Interact to see
Advertisement

TIQRX vs VTSAX

Header iconTIQRX vs VTSAX Comparison
Open Charts TIQRX vs VTSAXBanner chart's image
Nuveen Equity Index R
Price$42.39
Change-$0.50 (-1.17%)
VolumeN/A
Net Assets51.05B
Vanguard Total Stock Mkt Idx Adm
Price$142.91
Change-$1.69 (-1.17%)
VolumeN/A
Net Assets1.82T
TIQRX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TIQRX vs. VTSAX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TIQRX is a Buy and VTSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.82T vs. TIQRX (51.1B). VTSAX pays higher dividends than TIQRX: VTSAX (1.28) vs TIQRX (1.04). TIQRX was incepted earlier than VTSAX: TIQRX (19 years) vs VTSAX (25 years). TIQRX (0.30) is less costly to investors than VTSAX (0.04). TIQRX is a more actively managed with annual turnover of: 3.00 vs. VTSAX (2.00). TIQRX has a lower initial minimum investment than VTSAX: TIQRX (0) vs VTSAX (3000). TIQRX annual gain was more profitable for investors over the last year : 10.95 vs. VTSAX (10.07). TIQRX return over 5 years is better than : 98.25 vs. VTSAX (91.40).
TIQRXVTSAXTIQRX / VTSAX
Total Expense Ratio0.300.04750%
Annual Report Gross Expense Ratio0.300.04750%
Fund Existence19 years25 years-
Gain YTD1.6551.365121%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets51.1B1.82T3%
Annual Yield % from dividends1.041.2881%
Returns for 1 year10.9510.07109%
Returns for 3 years60.4357.61105%
Returns for 5 years98.2591.40107%
Returns for 10 years178.25179.5399%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTBP2.840.02
+0.71%
GT Biopharma
GMAB22.82-0.27
-1.17%
Genmab A/S ADS
FINW14.36-0.24
-1.64%
FinWise Bancorp
CENT34.21-1.31
-3.69%
Central Garden & Pet Company
CDLX1.51-0.09
-5.63%
Cardlytics